腹腔镜胆总管探查联合胆囊切除术治疗胆囊胆总管结石的安全性与疗效:最新Meta分析
该Meta分析比较LCBDE+LC与pre-EST+LC治疗胆囊胆总管结石的安全性和疗效,纳入13项研究共1757例患者。结果显示LCBDE+LC在结石清除率、围术期并发症、中转手术、结石残留、复发、手术时间、住院时间和总费用方面均优于pre-EST+LC,死亡率两组相似。
要点
- LCBDE+LC的胆总管结石清除率显著高于pre-EST+LC(94.1% vs 90.1%,OR 1.56,P=0.012)。
- LCBDE+LC的围术期并发症、中转手术、结石残留和复发率均显著低于pre-EST+LC。
- LCBDE+LC的手术时间、住院时间和总费用均显著低于pre-EST+LC。
核心结论
- LCBDE+LC在围术期安全性和短期及长期术后疗效方面均优于pre-EST+LC,应被视为胆囊胆总管结石的最佳治疗选择。
主要发现
- LCBDE+LC组与pre-EST+LC组的胆总管结石清除率分别为94.1%和90.1%(OR 1.56,P=0.012)。
- 围术期并发症发生率分别为7.6%和12.0%(OR 0.67,P=0.015),中转其他手术率分别为4.1%和7.1%(OR 0.64,P=0.025)。
- 结石残留率分别为1.2%和7.9%(OR 0.34,P=0.004),结石复发率分别为1.8%和5.6%(OR 0.32,P=0.005)。
- 手术时间分别为112.28分钟和132.03分钟(WMD -18.08,P=0.002),住院时间分别为4.94天和6.62天(WMD -1.63,P=0.023),总费用SMD -2.76(P=0.002)。
- 死亡率分别为0.6%和1.1%(OR 0.32,P=0.117),两组相似。
临床怎么用
- 对于胆囊胆总管结石患者,可优先考虑LCBDE+LC,因其结石清除率高且并发症、残留、复发及费用更低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of this study was to compare the efficacy and safety of the laparoscopic common bile duct exploration (LCBDE) and laparoscopic cholecystectomy (LC) with preoperative endoscopic sphincterotomy (pre-EST) and LC for concomitant gallstones and common bile duct (CBD) stones. BACKGROUND: It remains controversial whether LCBDE+LC is better than pre-EST+LC for gallstones and CBD stones. METHODS: A specific search of online databases was performed from January 2006 to October 2017. Relative outcomes of perioperative safety and postoperative efficacy were synthesized. Single-arm meta-analysis and cumulative meta-analysis were also conducted. RESULTS: A total of 13 studies involving 1757 (872 vs 885) patients were included for analysis in our study. The CBD stones clearance rate [94.1% vs 90.1%; odds ratio (OR) 1.56, P = 0.012] was significantly higher in patients who underwent LCBDE+LC than pre-EST+LC, while perioperative complications (7.6% vs 12.0%; OR 0.67, P = 0.015), conversion to other procedure (4.1% vs 7.1%; OR 0.64, P = 0.025), retained stones rate (1.2% vs 7.9%; OR 0.34, P = 0.004), lithiasis recurrence rate (1.8% vs 5.6%, OR 0.32, P = 0.005), operative time [112.28 vs 132.03 minutes; weighted mean difference (WMD) -18.08, P = 0.002], length of hospital stay (4.94 vs 6.62 days; WMD -1.63, P = 0.023), and total charges [standardized mean difference (SMD) -2.76, P = 0.002] were significantly lower in LCBDE+LC. The mortality (0.6% vs 1.1%; OR 0.32, P = 0.117) was similar between the 2 groups. The cumulative meta-analyses indicated the effect sizes of CBD stones clearance rate, perioperative complications, and conversion to other procedure have already stabilized between 2 groups. CONCLUSION: The updated meta-analysis first confirms that LCBDE+LC is superior to pre-EST+LC both in perioperative safety and short- and long-term postoperative efficacy, which should be considered as optimal treatment choice for cholecysto-choledocholithiasis.
引用
- Pan L, Chen M, Ji L, et al. The Safety and Efficacy of Laparoscopic Common Bile Duct Exploration Combined with Cholecystectomy for the Management of Cholecysto-choledocholithiasis: An Up-to-date Meta-analysis. Ann Surg. 2018. PMID: 29533266. doi:10.1097/SLA.0000000000002731
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。